1 - 25 of
48
results
for author:"Chu L."
in Literature Citations
| Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I. Chu L.W., Zhu Y., Yu K., Zheng T., Chokkalingam A.P., Stanczyk F.Z., Gao Y.T., Hsing A.W. Cancer Epidemiol. Biomarkers Prev. 17:3268-3273(2008) · Mapped (27) |
| Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Hsing A.W., Sakoda L.C., Rashid A., Andreotti G., Chen J., Wang B.S., Shen M.C., Chen B.E., Rosenberg P.S., Zhang M. et al. Cancer Res. 68:6442-6452(2008) · Mapped (120) |
| Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells. Dejosez M., Krumenacker J.S., Zitur L.J., Passeri M., Chu L.-F., Songyang Z., Thomson J.A., Zwaka T.P. |
| Identification of WSB1 gene as an important regulator in the development of zebrafish embryo during midblastula transition. Lv W., Zhang Y., Wu Z., Chu L., Koide S.S., Chen Y., Yan Y., Li Y. Acta Biochim. Biophys. Sin. (Shanghai) 40:478-488(2008) · Mapped (3) |
| In vivo validation of PAX2 as a target for renal cancer therapy. Hueber P.A., Iglesias D., Chu L.L., Eccles M., Goodyer P. Cancer Lett. 265:148-155(2008) · Mapped (5) |
| Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American women. Setiawan V.W., Chu L.H., John E.M., Ding Y.C., Ingles S.A., Bernstein L., Press M.F., Ursin G., Haiman C.A., Neuhausen S.L. Cancer Genet. Cytogenet. 181:16-19(2008) · Mapped (3) |
| Expression, purification and crystallization of human 5-lipoxygenase-activating protein with leukotriene-biosynthesis inhibitors. Xu S., McKeever B.M., Wisniewski D., Miller D.K., Spencer R.H., Chu L., Ujjainwalla F., Yamin T.T., Evans J.F., Becker J.W. et al. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 63:1054-1057(2007) · Mapped (1) |
| Dandruff-associated Malassezia genomes reveal convergent and divergent virulence traits shared with plant and human fungal pathogens. Xu J., Saunders C.W., Hu P., Grant R.A., Boekhout T., Kuramae E.E., Kronstad J.W., DeAngelis Y.M., Reeder N.L., Johnstone K.R. et al. Proc. Natl. Acad. Sci. U.S.A. 104:18730-18735(2007) · UniProtKB (4,274) |
| Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies. Danforth K.N., Hayes R.B., Rodriguez C., Yu K., Sakoda L.C., Huang W.Y., Chen B.E., Chen J., Andriole G.L., Calle E.E. et al. Carcinogenesis 29:568-572(2008) · Mapped (4) |
| Variants in circadian genes and prostate cancer risk: a population-based study in China. Chu L.W., Zhu Y., Yu K., Zheng T., Yu H., Zhang Y., Sesterhenn I., Chokkalingam A.P., Danforth K.N., Shen M.C. et al. Prostate Cancer Prostatic Dis. 11:342-348(2008) · Mapped (34) |
| Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein. Ferguson A.D., McKeever B.M., Xu S., Wisniewski D., Miller D.K., Yamin T.-T., Spencer R.H., Chu L., Ujjainwalla F., Cunningham B.R. et al. Science 317:510-512(2007) · UniProtKB (1) |
| Endothelial nitric oxide synthase is dynamically expressed during bone marrow stem cell differentiation into endothelial cells. Liu Z., Jiang Y., Hao H., Gupta K., Xu J., Chu L., McFalls E., Zweier J., Verfaillie C., Bache R.J. Am. J. Physiol. Heart Circ. Physiol. 293:H1760-5(2007) · Mapped (4) |
| A novel intronic polymorphism of ABCA1 gene reveals risk for sporadic Alzheimer's disease in Chinese. Chu L.W., Li Y., Li Z., Tang A.Y., Cheung B.M., Leung R.Y., Yik P.Y., Jin D.Y., Song Y.Q. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B:1007-1013(2007) · Mapped (10) |
| Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese patients. Li Y., Chu L.W., Chen Y.Q., Cheung B.M., Leung R.Y., Yik P.Y., Ng K.M., Mak W., Jin D.Y., St George-Hyslop P. et al. Dement Geriatr Cogn Disord 22:399-404(2006) · Mapped (4) |
| Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats. Fang S.H., Wei E.Q., Zhou Y., Wang M.L., Zhang W.P., Yu G.L., Chu L.S., Chen Z. Neuroscience 140:969-979(2006) · Mapped (1) |
| Adenoviral vector expressing CYLD augments antitumor activity of TRAIL by suppression of NF-kappaB survival signaling in hepatocellular carcinoma. Chu L., Gu J., He Z., Xiao T., Liu X. Cancer Biol. Ther. 5:615-622(2006) · Mapped (7) |
| Expression of FoxP2 during zebrafish development and in the adult brain. Shah R., Medina-Martinez O., Chu L.F., Samaco R.C., Jamrich M. Int. J. Dev. Biol. 50:435-438(2006) · Mapped (1) |
| PAX2 activates WNT4 expression during mammalian kidney development. Torban E., Dziarmaga A., Iglesias D., Chu L.L., Vassilieva T., Little M., Eccles M., Discenza M., Pelletier J., Goodyer P. J. Biol. Chem. 281:12705-12712(2006) · Mapped (6) |
| Zebrafish id2 developmental expression pattern contains evolutionary conserved and species-specific characteristics. Chong S.W., Nguyen T.T., Chu L.T., Jiang Y.J., Korzh V. Dev. Dyn. 234:1055-1063(2005) · Mapped (1) |
| Bax-regulated mitochondria-mediated apoptosis is responsible for the in vitro ischemia induced neuronal cell death of Sprague Dawley rat. Lin C.H., Lu Y.Z., Cheng F.C., Chu L.F., Hsueh C.M. Neurosci. Lett. 387:22-27(2005) · Mapped (1) |
| Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner. Ray D., Terao Y., Nimbalkar D., Chu L.H., Donzelli M., Tsutsui T., Zou X., Ghosh A.K., Varga J., Draetta G.F. et al. Mol. Cell. Biol. 25:3338-3347(2005) · Mapped (5) |
| Dimerize RACK1 upon transformation with oncogenic ras. Chu L.Y., Chen Y.H., Chuang N.N. Biochem. Biophys. Res. Commun. 330:474-482(2005) · Mapped (1) |
| Expression and role of early growth response gene-1 in experimental silicosis of rat. Chu L., Li X., Hu Y.B., Wang J.S., Zheng H., Zeng Q.F. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 22:47-50(2004) · Mapped (1) |
| Complete sequence and evolutionary genomic analysis of the Pseudomonas aeruginosa transposable bacteriophage D3112. Wang P.W., Chu L., Guttman D.S. J. Bacteriol. 186:400-410(2004) · UniProtKB (55) |
| WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2. Discenza M.T., He S., Lee T.H., Chu L.L., Bolon B., Goodyer P., Eccles M., Pelletier J. Oncogene 22:8145-8155(2003) · Mapped (10) |
